TCTMD's Todd Neale spoke with Warraich about the ADVOCATE program, which has its sights set on heart failure first.

Seamlessly merging the AHA’s new CV risk calculators into the country’s largest electronic health record system marks a big ...

William Fearon and C. Michael Gibson break down the final 5-year follow-up of the study comparing FFR-guided PCI vs CABG for ...

The guidelines introduce the “STAMP” acronym to help physicians in caring for patients with CKD: Screen, Triage, Address CKD ...

HF with mildly reduced EF is gone, stages are updated, and new classifications for medical and interventional therapies are ...

Investigators stressed that the method is simple, doesn’t require ultrasound, and can be done with existing cath lab ...

CRF ® is committed to igniting the next wave of innovation in research and education that will help docto ...

Asymptomatic patients will now be covered and more flexibility has been given to heart teams for individualizing patient care ...

The latest UDMI aims to align classifications with pathology and clinical practice, bringing numerous changes to the 2018 ...

Novartis announced that the phase III CV outcomes trial did not meet its primary endpoint, raising doubts over Lp(a)’s role.

The data “give you pause” when considering closure, especially for women who can tolerate DOACs, Christine Albert says.

It’s unlikely a lipid-lowering agent can directly reduce infection or malignancy, but some argue it could stop a domino ...